Schedule of Events

Past Events

Virtual Clinical Conference on Bartonella: April 5 – May 5, 2021

Learn from some of the world’s foremost experts on Bartonellosis.

Gain a detailed medical understanding of why chronic Bartonella infection drives many autoimmune diseases. Come away from this educational event with a clear path on how to identify and treat patients suffering from Bartonella.

Topics covered include:

  • General medical overview of Bartonellosis–Dr. Alexander Shikhman
  • Rheumatological manifestations of Bartonellosis–Dr. Alexander Shikhman
  • Diverse manifestations and persistence of Bartonellosis–Dr. Monica Embers
  • Comparative medical observations relative to Bartonellosis in dogs and humans–Dr. Ed Breitschwerdt
  •  Principles of Bartonellosis therapy–Dr. Alexander Shikhman
  • Laboratory diagnosis: current practices, challenges and recent developments–Dr. Jennifer Miller
  • Bartonella in Pediatrics–Neenah Grade, PA-C
Feedback on 2021 Virtual Bartonella Conference 

“This seminar has BLOWN MY MIND….incredible. I am in awe that you can treat these difficult patients without the massive dosing I have been trained to do.”

“His whole approach to these infections….and his ability to help some of these autoimmune diseases with his approach is unique and new to me and his results are far superior to mine.”

“The conference was so helpful and so well done.  I learned more about Bartonella from this conference than I have learned in the previous ten years.  Bravo.”

Alexander Shikhman, MD PhD

IAREF President, Dr. Alexander Shikhman, is board certified in internal medicine and rheumatology. He is also CEO and owner of Institute for Specialized Medicine, a private rheumatology practice in San Diego, CA. He is a highly sought after physician for diagnosing and treating the connection between autoimmune disease and chronic infections. 

Dr. Shikhman’s Presentations:

Chronic Infections and Autoimmunity

  • Defining the chronic infectious process
  • Chronic infections as driving forces behind autoimmune disease 
  • Diagnosing infection driven autoimmune process 
  • Principles of therapy

Bartonellosis and Rheumatic Diseases

  • Early Sjogren’s syndrome
  • Calcium Pyrophosphate Deposition
  • Tendinopathies
  • Connective tissue diseases
  • Ultrasound examples
  • Preferred anti-rheumatic drugs

Therapy of Bartonellosis

  • Goals of antimicrobial therapy
  • Treatment of autoimmune complications
  • Treatment of metabolic and endocrine complications
  • Successful uses of antibiotic, botanical, and nutraceutical therap AuD

Edward Breitschwerdt, DVM

Dr. Edward B. Breitschwerdt is a professor of medicine and infectious diseases at North Carolina State University College of Veterinary Medicine.  He is also an adjunct professor of medicine at Duke University Medical Center, and a Diplomate, American College of Veterinary Internal Medicine (ACVIM).  Dr. Breitschwerdt directs the Intracellular Pathogens Research Laboratory in the Comparative Medicine Institute at North Carolina State University.  He also co-directs the Vector Borne Diseases Diagnostic Laboratory. For over 30 years, his research has emphasized vector-transmitted, intracellular pathogens.  Most recently, his research group has contributed to cutting-edge research in the areas of animal and human bartonellosis. 

Dr. Breitschwerdt’s Presentation:

Comparative medical observations relative to bartonellosis in dogs and humans

  • Discuss typical and atypical disease manifestations associated with bartonelloses
  • Describe benefits and limitations of serological, molecular and enrichment culture tests for diagnosis of bartonellosis
  • Review potential sources of Bartonella spp. exposures and modes of organism transmission
  • Discuss the role of Bartonella spp. in sudden death and vasoproliferative cancers 


Jennifer Miller, PhD

Director of Research and Development and Assistant Laboratory Director at Galaxy Labs, Dr. Miller holds a doctorate in microbiology, immunology, and molecular genetics. With over 20 years of experience with vector-borne and zoonotic pathogens, including Borrelia burgdorferi and Leptospira interrogans, the causative agent of Leptospirosis, Dr. Miller leads clinical assay development and the diagnostic test portfolio at Galaxy. Her experience as a professor of microbiology at North Carolina State University, where she developed her own research program and laboratory focused on in vitro and murine studies of vector-borne diseases.

Dr. Miller’s Presentation:

Laboratory diagnosis of bartonellosis: current practices, challenges, and recent developments

  • Currently utilized laboratory tests for the diagnosis of bartonellosis
  • Challenges associated with currently utilized laboratory tests
  • Barriers to new assay development
  • Recent advances in new assay development

Monica Embers, Ph.D.

Monica E. Embers obtained her Ph.D. in the Department of Microbiology and Immunology at the Pennsylvania State University College of Medicine in Hershey, P.A., where she studied immune responses to Papillomaviruses.  She made the transition to the study of bacterial pathogenesis when performing her postdoctoral research on the Lyme disease spirochete at the Tulane National Primate Research Center (TNPRC).  She subsequently joined the faculty at the TNPRC.  Dr. Embers is an Associate Professor in the Division of Immunology and the Director of Vector borne Disease Research at the TNPRC. 

Dr. Embers’s Presentation:

The Diversity of Bartonellosis Manifestations and Challenges to Treatment

  • Describe the possible clinical presentations (signs and symptoms) of Bartonellosis
  • Compare Bartonellosis to Lyme borreliosis in terms of detection, persistence and treatment
  • Describe research efforts needed to better diagnose and cure Bartonellosis
neenah ultrasound2 (2)

Neenah Grade, PA-C

Neenah Grade is a board certified Physician Assistant with a background in primary care and integrative pain medicine. She received a Bachelor’s degree in genetics, cell and molecular biology from Arizona State University before completing her Masters in Science at Arcadia University in Philadelphia.

She and Dr. Shikhman have developed protocols specific to pediatric infectious and autoimmune conditions.

Neenah’s Presentation:

Bartonella and Pediatrics

  • Focus on three case studies of children with Bartonella as a driving factor for:
  • Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)
  • Autoimmune Hepatitis
  • Inflammatory joint pain